A randomized controlled trial in two general practices in Cambridgeshire compared the effect of loss and gain framed messages in an invitation to screening for type 2 diabetes on uptake and subsequent anxiety and self-rated health. High risk individuals aged 40—69 years were randomized to receive loss (n = 57) or gain (n = 59) framed screening invitations. A postal questionnaire was sent to all participants, including non-attenders, after six weeks. There were no significant differences in attendance, mean state anxiety, self-rated health or illness representation between the loss and gain frame arms. Framing of information in diabetes screening invitations does not influence uptake.
Banks, S.M., Salovey, P., Greener, S., Rothman, A.J., Moyer, A., Beauvais, J. et al. (1995). The effects of message framing on mammography utilization. Health Psychology, 14, 178-184.
2.
Campbell, S.M., Roland, M.O., Middleton, E., & Reeves, D. ( 2005). Improvements in quality of clinical care in English general practice 1998-2003: Longitudinal observational study. British Medical Journal, 331, 1121.
3.
Detweiler, J.B., Bedell, B.T., Salovey, P., Pronin, E., & Rothman, A.J. ( 1999). Message framing and sunscreen use: Gain-framed messages motivate beach-goers. Health Psychology, 18, 189-196.
4.
Dong, W., Hedges, B., Lampe, F., & Taylor, A. ( 1996). Health survey for England 1994. London: HMSO.
5.
Doran, T., Fullwood, C., Gravelle, H., Reeves, D., Kontopantelis, E., Hiroeh, U. et al. (2006). Pay-for-performance programs in family practices in the United Kingdom. New England Journal of Medicine, 355, 375-384.
6.
Eborall, H., Davies, R., Kinmonth, A.L., Griffin, S., & Lawton, J. ( 2007a). Patients’ experiences of screening for type 2 diabetes: Prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial. British Medical Journal, 335, 490.
7.
Eborall, H.C., Griffin, S.J., Prevost, A.T., Kinmonth, A.L., French, D.P., & Sutton, S. ( 2007b). Psychological impact of screening for type 2 diabetes: Controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. British Medical Journal , 335, 486.
8.
Edwards, A., Elwyn, G., Covey, J., Matthews, E., & Pill, R. ( 2001). Presenting risk information: A review of the effects of ‘framing’ and other manipulations on patient outcomes. Journal of Health Communication, 6, 61-82.
9.
Forouhi, N.G., Merrick, D., Goyder, E., Ferguson, B.A., Abbas, J., Lachowycz, K. et al. (2006). Diabetes prevalence in England, 2001: Estimates from an epidemiological model. Diabetic Medicine, 23, 189-197.
10.
Griffin, S.J., Little, P.S., Hales, C.N., Kinmonth, A.L., & Wareham, N.J. ( 2000). Diabetes risk score: Towards earlier detection of type 2 diabetes in general practice. Diabetes/Metabolism Research and Reviews, 16, 164-171.
11.
Harris, M.I. ( 1993). Undiagnosed NIDDM: Clinical and public health issues . Diabetes Care, 16, 642-652.
12.
Harris, M.I., Hadden, W.C., Knowler, W.C., & Bennett, P.H. ( 1987). Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes, 36, 523-534.
13.
Harris, M.I., Klein, R., Welborn, T.A., & Knuiman, M.W. ( 1992). Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care, 15, 815-819.
14.
Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R., & Neil, H.A. ( 2008). 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine, 359, 1577-1589.
15.
Johnstone, M. ( 1999). Mood in chronic disease: Questioning the answers . Current Psychology, 18, 71-87.
16.
Kerbel, D., Glazier, R., Holzapfel, S., Yeung, M., & Lofsky, S. ( 1997). Adverse effects of screening for gestational diabetes: A prospective cohort study in Toronto, Canada. Journal of Medical Screening, 4, 128-132.
17.
Lauritzen, T., Griffin, S., Borch-Johnsen, K., Wareham, N.J., Wolffenbuttel, B.H., & Rutten, G. ( 2000). The ADDITION study: Proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. International Journal of Obesity and Related Metabolic Disorders, 24(Suppl 3), S6-11.
18.
Lauver, D., & Rubin, M. ( 1990). Message framing, dispositional optimism, and follow-up for abnormal Papanicolaou tests. Research in Nursing and Health , 13, 199-207.
19.
Leventhal, H., Nerenz, D.R., & Steele, D.J. ( 1984). Illness representations and coping with health threats . In A. Baum, S. E. Taylor, & J. E. Singer (Eds.), Handbook of psychology and health, volume IV: Social psychological aspects of health (pp. 219-252). Hillsdale, NJ: Erlbaum.
20.
Marteau, T.M., & Bekker, H. ( 1992). The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). British Journal of Clinical Psychology, 31(Pt 3), 301-306.
21.
Moss-Morris, R., Weinman, J., Petrie, K.J., Horne, R., Cameron, L.D., & Buick, D. ( 2002). The revised illness perception questionnaire (IPQ-R) . Psychology & Health, 17, 1-16.
22.
Murphy, E., & Kinmonth, A.L. (1995). No symptoms, no problem? Patients’ understandings of non-insulin dependent diabetes. Family Practice, 12, 184-192.
23.
O’Keefe, J.H., & Jensen, J.D. ( 2006). The advantages of compliance or the disadvantages of noncompliance?A meta-analytic review of the relative persuasive effectiveness of gain-framed and loss-framed messages. Communication Yearbook , 30, 1-43.
24.
Park, P., Simmons, R.K., Prevost, A.T., & Griffin, S.J. ( 2008). Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: A randomised controlled trial in British general practice. BMC Public Health, 8, 350.
25.
Puavilai, G., Chanprasertyotin, S., & Sriphrapradaeng, A. (1999). Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Research and Clinical Practice, 44, 21-26.
26.
Rees, G., Fry, A., Cull, A., & Sutton, S. ( 2004). Illness perceptions and distress in women at increased risk of cancer. Psychology & Health, 19, 749-765.
27.
Rothman, A.J., & Salovey, P. ( 1997). Shaping perceptions to motivate healthy behavior: The role of message framing. Psychological Bulletin, 121, 3-19.
28.
Shaw, C., Abrams, K., & Marteau, T.M. ( 1999). Psychological impact of predicting individuals’ risks of illness: A systematic review. Social Science & Medicine, 49, 1571-1598.
29.
Tversky, A., & Kahneman, D. ( 1981). The framing of decisions and the psychology of choice . Science, 211, 453-458.
30.
UKPDS. (1990). UK Prospective Diabetes Study 6: Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors . Diabetes Research, 13, 1-11.
31.
VanDercar, D.H., Greaner, J., Hibler, N.S., Spielberger, C.D., & Bloch, S. ( 1980). A description and analysis of the operation and validity of the psychological stress evaluator. Journal of Forensic Science, 25, 174-188.
32.
Wareham, N.J., & Griffin, S.J. ( 2001). Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. British Medical Journal , 322, 986-988.
33.
Weinman, J., Petrie, K.J., Moss-Morris, R., & Horne, R. ( 1996). The illness perception questionnaire: A new method of assessing the cognitive representation of illness. Psychology & Health, 11, 431-445.
34.
Whitford, D.L., Lamont, S.S., & Crosland, A. ( 2003). Screening for Type 2 diabetes: Is it worthwhile? Views of general practitioners and practice nurses. Diabetic Medicine , 20, 155-158.
35.
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. ( 2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-1053.
